CIPO Patents = 4

EPO Patents = 3

Forward Citations = 28

Loading Chart...

50 inventors (with patents filed for the assignee):

Feng Tang (2 out of 7 patents)

Qiu Jin (2 out of 3 patents)

Xiaojin Yin (2 out of 2 patents)

4. Jian He (1 out of 41 patents)

5. Xin Huang (1 out of 4 patents)

6. Yongke Zhang (1 out of 14 patents)

7. Weimin Zhu (1 out of 19 patents)

8. Yaohuang Ke (1 out of 16 patents)

9. Shibao Yang (1 out of 3 patents)

10. Zheng Jiang (1 out of 2 patents)

11. Tian Zhu (1 out of 1 patent)

12. Yang Hu (1 out of 1 patent)

13. Feng Shao (1 out of 1 patent)

14. Pierre Li (1 out of 1 patent)

15. Guoliang Yu (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 9018242 - Salt form of tyrosine kinase inhibitor (2015-04-28),

2. 8986692 - Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody (2015-03-24),

3. 8802824 - Modified recombinant human endostatin and uses thereof (2014-08-12),

4. 8658684 - Pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases (2014-02-25),

5. 8084621 - [object Object] (2011-12-27),

Jiangsu Simcere Pharmaceutical R&D Co., Ltd is a leading pharmaceutical company in China, focusing on research and development of innovative drugs. With a strong commitment to quality and innovation, the company has a proven track record of bringing new therapies to market. They specialize in oncology, central nervous system disorders, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#69 in Nanjing

#4,566 in China

Nanjing, China

Jiangsu Simcere Pharmaceutical R&d Co., Ltd

Forward Citations = 28

50 inventors:

Feng Tang (2 out of 7 patents)

Qiu Jin (2 out of 3 patents)

Xiaojin Yin (2 out of 2 patents)

4. Jian He (1 out of 41 patents)

5. Xin Huang (1 out of 4 patents)

Please report any incorrect information to support@idiyas.com

4 patents (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com